Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Can the Use of Intra Arterial Vasodilators Prevent Radial Artery Occlusion?

The incidence of post procedure radial occlusion (RAO) ranges from 1% to 12 % according to some studies. Different strategies to reduce RAO include the use of small caliber catheters, adequate anticoagulation and punction site care after procedure. 

¿Es útil el uso de vasodilatadores intra-arteriales para prevenir la oclusión de la arteria radial?

Vasodilators are used to prevent radial spasm during procedure. However, using it after procedure should increase flow, improving hemostasis, and preventing RAO. 

The aim of this prospective, multicenter, randomized, double blind study was to assess whether the administration of nitroglycerin at the beginning or at the end of procedure might preserve radial artery patency compared against placebo. 

Primary end point was early RAO incidence confirmed by ultrasound up to 24 hrs. after procedure. Secondary end point was late RAO (30 days after procedure). 

It included 2040 patients. Mean age was 61 and 38% were women. The right radial artery was the most used (99.9%), and catheterization was the most frequent diagnostic procedure. 

Read also: Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus after ST-Segment Elevation Acute Coronary Syndrome

There were no significant differences when looking at primary and secondary end points. The presence of recanalization at 30 days assessed by Doppler was 30% with no differences between the groups.  

At multivariable analysis, the presence of radial spasm and access achieved with more than one puncture attempt were independent predictors of RAO at 24 hrs. 

Conclusion

The use of nitroglycerin was not associated with reduced RAO rate, regardless of time of administration, and therefore it should not be considered mandatory to prevent this complication. 

Dr. Andrés Rodríguez.
Member of the Editorial Board in SOLACI.org .

Original Title: Randomized Clinical Trial on Prevention of Radial Occlusion After Transradial Access Using Nitroglycerin PATENS Trial.

Reference: Roberto L. da Silva, MD et al J Am Coll Cardiol Intv 2022.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...